Innate Immune Recognition of Mycobacterium tuberculosis

Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is a major health problem, with 10 million new cases diagnosed each year. Innate immunity plays an important role in the host defense against M. tuberculosis, and the first step in this process is recognition of MTB by cells of the innate immune system. Several classes of pattern recognition receptors (PPRs) are involved in the recognition of M. tuberculosis, including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), and Nod-like receptors (NLRs). Among the TLR family, TLR2, TLR4, and TLR9 and their adaptor molecule MyD88 play the most prominent roles in the initiation of the immune response against tuberculosis. In addition to TLRs, other PRRs such as NOD2, Dectin-1, Mannose receptor, and DC-SIGN are also involved in the recognition of M. tuberculosis. Human epidemiological studies revealed that genetic variation in genes encoding for PRRs and downstream signaling products influence disease susceptibility, severity, and outcome. More insight into PRRs and the recognition of mycobacteria, combined with immunogenetic studies in TB patients, does not only lead to a better understanding of the pathogenesis of tuberculosis but also may contribute to the design of novel immunotherapeutic strategies.

[1]  Hong Yang,et al.  Toll-like receptors, tumor necrosis factor-α, and interleukin-10 gene polymorphisms in risk of pulmonary tuberculosis and disease severity. , 2010, Human immunology.

[2]  Brijendra Singh,et al.  Toll-like receptor and TIRAP gene polymorphisms in pulmonary tuberculosis patients of South India. , 2010, Tuberculosis.

[3]  L. Joosten,et al.  Mycobacterium tuberculosis induces IL‐17A responses through TLR4 and dectin‐1 and is critically dependent on endogenous IL‐1 , 2010, Journal of leukocyte biology.

[4]  Z. Zhao,et al.  Toll‐like receptors 2 and 4 gene polymorphisms in a southeastern Chinese population with tuberculosis , 2010, International journal of immunogenetics.

[5]  M. Leal,et al.  The TLR4 ASP299GLY polymorphism is a risk factor for active tuberculosis in Caucasian HIV-infected patients. , 2010, Current HIV research.

[6]  L. Schlesinger,et al.  Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. , 2010, Tuberculosis.

[7]  Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced IL-6 secretion , 2010, Genes and Immunity.

[8]  Chung-Jen Chen,et al.  Toll-like receptor 2 gene polymorphisms, pulmonary tuberculosis, and natural killer cell counts , 2010, BMC Medical Genetics.

[9]  M. Netea,et al.  Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis. , 2009, The Journal of infectious diseases.

[10]  H. Takata,et al.  Identification of Mycobacterial α-Glucan As a Novel Ligand for DC-SIGN: Involvement of Mycobacterial Capsular Polysaccharides in Host Immune Modulation1 , 2009, The Journal of Immunology.

[11]  S. Gupta,et al.  TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients , 2009, BMC Research Notes.

[12]  G. Besra,et al.  Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death. , 2009, Glycobiology.

[13]  L. Joosten,et al.  Transcriptional and inflammasome‐mediated pathways for the induction of IL‐1β production by Mycobacterium tuberculosis , 2009, European journal of immunology.

[14]  G. Superti-Furga,et al.  An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome , 2009, Nature Immunology.

[15]  M. Behr,et al.  NOD2-Deficient Mice Have Impaired Resistance to Mycobacterium tuberculosis Infection through Defective Innate and Adaptive Immunity1 , 2008, The Journal of Immunology.

[16]  S. Akira,et al.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production , 2008, Nature.

[17]  S. Nejentsev,et al.  Genetic Association and Expression Studies Indicate a Role of Toll-Like Receptor 8 in Pulmonary Tuberculosis , 2008, PLoS genetics.

[18]  B. Alisjahbana,et al.  Mycobacterium tuberculosis Population Structures Differ Significantly on Two Indonesian Islands , 2008, Journal of Clinical Microbiology.

[19]  J. Yim,et al.  Association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and nontuberculous mycobacterial lung disease in a Korean population. , 2008, Human immunology.

[20]  Ana M. Rojas,et al.  The Nod-Like Receptor (NLR) Family: A Tale of Similarities and Differences , 2008, PloS one.

[21]  S. Ehlers,et al.  Mycobacterium tuberculosis prevents inflammasome activation. , 2008, Cell host & microbe.

[22]  T. van der Poll,et al.  The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium–host interaction , 2008, Cellular microbiology.

[23]  J. Todd,et al.  Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations , 2008, Nature Genetics.

[24]  J. Farrar,et al.  The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis , 2008, PLoS pathogens.

[25]  C. Thompson,et al.  Autophagy: basic principles and relevance to disease. , 2008, Annual review of pathology.

[26]  G. Sirugo,et al.  CD209 Genetic Polymorphism and Tuberculosis Disease , 2008, PloS one.

[27]  A. Clark,et al.  Full-Exon Resequencing Reveals Toll-Like Receptor Variants Contribute to Human Susceptibility to Tuberculosis Disease , 2007, PloS one.

[28]  F. Martinon.  Orchestration of pathogen recognition by inflammasome diversity: Variations on a common theme , 2007, European journal of immunology.

[29]  H. Eng,et al.  Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. , 2007, Translational research : the journal of laboratory and clinical medicine.

[30]  L. Quintana-Murci,et al.  Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients. , 2007, Human immunology.

[31]  M. Netea,et al.  Mycobacterium paratuberculosis is recognized by Toll‐like receptors and NOD2 , 2007, Journal of leukocyte biology.

[32]  A. Sher,et al.  Dectin-1 Interaction with Mycobacterium tuberculosis Leads to Enhanced IL-12p40 Production by Splenic Dendritic Cells1 , 2007, The Journal of Immunology.

[33]  S. Gandotra,et al.  Nucleotide-Binding Oligomerization Domain Protein 2-Deficient Mice Control Infection with Mycobacterium tuberculosis , 2007, Infection and Immunity.

[34]  A. Sharafkhaneh,et al.  Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. , 2007, Immunity.

[35]  B. Ryffel,et al.  IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection , 2007, The Journal of Immunology.

[36]  R. Tapping,et al.  Cutting Edge: A Common Polymorphism Impairs Cell Surface Trafficking and Functional Responses of TLR1 but Protects against Leprosy1 , 2007, The Journal of Immunology.

[37]  A. Aderem,et al.  A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis , 2007, Genes and Immunity.

[38]  M. Netea,et al.  The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania , 2007, AIDS.

[39]  Y. Kooyk,et al.  C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB , 2007 .

[40]  S. Hickman,et al.  Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to Mycobacterium tuberculosis Is Due to Use of Distinct TLRs1 , 2007, The Journal of Immunology.

[41]  Giorgio Sirugo,et al.  A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.

[42]  Peter M. Small,et al.  The W-Beijing Lineage of Mycobacterium tuberculosis Overproduces Triglycerides and Has the DosR Dormancy Regulon Constitutively Upregulated , 2007, Journal of bacteriology.

[43]  P. V. van Helden,et al.  Length Variation of DC-SIGN and L-SIGN Neck-Region has no Impact on Tuberculosis Susceptibility , 2006, Human Immunology.

[44]  Young Keun Kim,et al.  Lack of Toll-like Receptor 4 and 2 Polymorphisms in Korean Patients with Bacteremia , 2006, Journal of Korean medical science.

[45]  A. Hill.  Aspects of genetic susceptibility to human infectious diseases. , 2006, Annual review of genetics.

[46]  M. Yadav,et al.  The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. , 2006, Blood.

[47]  Javier Martín,et al.  Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis. , 2006, Human immunology.

[48]  R. Bellamy.  Genome-wide approaches to identifying genetic factors in host susceptibility to tuberculosis. , 2006, Microbes and infection.

[49]  J. Yim,et al.  The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans , 2006, Genes and Immunity.

[50]  T. Ottenhoff,et al.  Phenotypic and functional profiling of human proinflammatory type‐1 and anti‐inflammatory type‐2 macrophages in response to microbial antigens and IFN‐γ‐ and CD40L‐mediated costimulation , 2006, Journal of leukocyte biology.

[51]  T. Mak,et al.  Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Lluis Quintana-Murci,et al.  Promoter Variation in the DC-SIGN–Encoding Gene CD209 Is Associated with Tuberculosis , 2006, PLoS medicine.

[53]  A. Sher,et al.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis , 2005, The Journal of experimental medicine.

[54]  M. Netea,et al.  NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis , 2005, PLoS pathogens.

[55]  A. Azad,et al.  The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis , 2005, The Journal of experimental medicine.

[56]  M. Reed,et al.  Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. , 2005, The Journal of infectious diseases.

[57]  Mahavir Singh,et al.  Mycobacterium Tuberculosis Heat Shock Proteins Use Diverse Toll-like Receptor Pathways to Activate Pro-inflammatory Signals* , 2005, Journal of Biological Chemistry.

[58]  I. Maridonneau-Parini,et al.  Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400308-JLR200 , 2005, Journal of Lipid Research.

[59]  D. Malhotra,et al.  TLR2 Arg677Trp polymorphism in leprosy: revisited , 2005, Human Genetics.

[60]  V. Deretic,et al.  Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages , 2004, Cell.

[61]  F. Martinon,et al.  Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome , 2004, Current Biology.

[62]  M. Reed,et al.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.

[63]  G. Besra,et al.  Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response , 2004, Molecular microbiology.

[64]  F. Martinon,et al.  Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.

[65]  M. Barbouche,et al.  Toll-Like Receptor 2 Arg677Trp Polymorphism Is Associated with Susceptibility to Tuberculosis in Tunisian Patients , 2004, Clinical Diagnostic Laboratory Immunology.

[66]  N. Reiner,et al.  Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1α,25-dihydroxyvitamin D3–phosphoinositide 3-kinase pathway , 2004, Journal of Cell Science.

[67]  Matthijs Kramer,et al.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[68]  A. Lemassu,et al.  Revisiting the Structure of the Anti-neoplastic Glucans of Mycobacterium bovis Bacille Calmette-Guérin , 2004, Journal of Biological Chemistry.

[69]  B. Yoldaş,et al.  The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease , 2004, European Respiratory Journal.

[70]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[71]  S. Akira,et al.  MyD88 Primes Macrophages for Full-Scale Activation by Interferon-γ yet Mediates Few Responses to Mycobacterium tuberculosis , 2003, The Journal of experimental medicine.

[72]  Shizuo Akira,et al.  Toll-like Receptor Signaling* , 2003, Journal of Biological Chemistry.

[73]  Vojo Deretic,et al.  Tuberculosis Toxin Blocking Phagosome Maturation Inhibits a Novel Ca2+/Calmodulin-PI3K hVPS34 Cascade , 2003, The Journal of experimental medicine.

[74]  R. Tapping,et al.  Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. , 2003, Journal of endotoxin research.

[75]  S. Gordon,et al.  Dectin-1 Mediates the Biological Effects of β-Glucans , 2003, The Journal of experimental medicine.

[76]  Shizuo Akira,et al.  Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2 , 2003, The Journal of experimental medicine.

[77]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[78]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[79]  N. Reiling,et al.  Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.

[80]  B. Ryffel,et al.  Toll-Like Receptor 4 Expression Is Required to Control Chronic Mycobacterium tuberculosis Infection in Mice1 , 2002, The Journal of Immunology.

[81]  T. Ottenhoff,et al.  Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae , 2002, Nature Genetics.

[82]  T. Ottenhoff,et al.  Innate Immunity to Mycobacterium tuberculosis , 2002, Clinical Microbiology Reviews.

[83]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[84]  G. Puzo,et al.  Mannosylated Lipoarabinomannans Inhibit IL-12 Production by Human Dendritic Cells: Evidence for a Negative Signal Delivered Through the Mannose Receptor1 , 2001, The Journal of Immunology.

[85]  J. Belisle,et al.  Different Toll‐like receptor agonists induce distinct macrophage responses , 2001, Journal of leukocyte biology.

[86]  N. Reiling,et al.  Mycobacterium avium infection in CD14‐deficient mice fails to substantiate a significant role for CD14 in antimycobacterial protection or granulomatous inflammation , 2001, Immunology.

[87]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[88]  N. Schluger.  Recent advances in our understanding of human host responses to tuberculosis , 2001, Respiratory research.

[89]  J. Keane,et al.  Differential Effects of a Toll-Like Receptor Antagonist on Mycobacterium tuberculosis-Induced Macrophage Responses1 , 2001, The Journal of Immunology.

[90]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[91]  D. Umetsu,et al.  Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells. , 2001, The Journal of allergy and clinical immunology.

[92]  Carl G. Figdor,et al.  DC-SIGN–ICAM-2 interaction mediates dendritic cell trafficking , 2000, Nature Immunology.

[93]  T. van der Poll,et al.  Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. , 2000, The Journal of infectious diseases.

[94]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[95]  Y. Iwakura,et al.  Protective Role of Interleukin-1 in Mycobacterial Infection in IL-1 α/β Double-Knockout Mice , 2000, Laboratory Investigation.

[96]  C. Figdor,et al.  Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.

[97]  H. Kolb,et al.  Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1 , 2000, The Journal of Immunology.

[98]  A. Aderem,et al.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[99]  D. Golenbock,et al.  Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.

[100]  M. Fenton,et al.  Roles of lipoarabinomannan in the pathogenesis of tuberculosis. , 1999, Microbes and infection.

[101]  J. Casanova,et al.  Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. , 1998, Science.

[102]  F. Deist,et al.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.

[103]  K. Edwards,et al.  SP-A enhances uptake of bacillus Calmette-Guérin by macrophages through a specific SP-A receptor. , 1997, The American journal of physiology.

[104]  J. Ernst,et al.  Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. , 1996, American journal of respiratory cell and molecular biology.

[105]  J T Douglas,et al.  Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia , 1995, Journal of clinical microbiology.

[106]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[107]  J. Ellner,et al.  Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. , 1994, Journal of immunology.

[108]  H. Yeager,et al.  Nonopsonic uptake of Mycobacterium avium complex by human monocytes and alveolar macrophages. , 1992, The Journal of laboratory and clinical medicine.

[109]  M. Horwitz,et al.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.

[110]  V. Kindler,et al.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.

[111]  R. Dubos,et al.  The White Plague: Tuberculosis, Man and Society , 1987 .

[112]  G. Toews,et al.  Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. , 1986, Journal of immunology.

[113]  J. Armstrong,et al.  Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival , 1975, The Journal of experimental medicine.

[114]  P. D. Hart,et al.  RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES , 1971, The Journal of experimental medicine.

[115]  D. Jewell,et al.  NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.

[116]  D. Philpott,et al.  Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.

[117]  J. Gilbert,et al.  Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans , 2009, Human Genetics.

[118]  S. Gringhuis,et al.  C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. , 2007, Immunity.

[119]  M. Newport,et al.  The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. , 2004, Tuberculosis.

[120]  B. Ryffel,et al.  Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. , 2004, The American journal of pathology.

[121]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[122]  H. Nikaido,et al.  The envelope of mycobacteria. , 1995, Annual review of biochemistry.